1.
Lopes-Ramos CM, Kuijjer ML, Ogino S, et al. Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism. Cancer Res. 2018;78(19):5538-5547. doi:10.1158/0008-5472.CAN-18-0454.
1.
Lavoie S, Garrett WS. The Unfolding Story of ATF6, Microbial Dysbiosis, and Colorectal Cancer. Gastroenterology. 2018;155(5):1309-1311. doi:10.1053/j.gastro.2018.10.011.
1.
Van Blarigan EL, Ou F-S, Niedzwiecki D, et al. Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018;27(10):1227-1230. doi:10.1158/1055-9965.EPI-18-0487.
1.
Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156-1160. doi:10.1126/science.aah5043.
1.
Pardini B, Corrado A, Paolicchi E, et al. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020;146(2):363-372. doi:10.1002/ijc.32516.
1.
Ogino S, Giannakis M. Immunoscore for (colorectal) cancer precision medicine. Lancet. 2018;391(10135):2084-2086. doi:10.1016/S0140-6736(18)30953-X.
1.
Abed J, Maalouf N, Manson AL, et al. Colon Cancer-Associated May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System. Front Cell Infect Microbiol. 2020;10:400. doi:10.3389/fcimb.2020.00400.
1.
Hassig CA, Tong JK, Schreiber SL. Fiber-derived butyrate and the prevention of colon cancer. Chem Biol. 1997;4(11):783-9.
1.
Gu H, Bock C, Mikkelsen TS, et al. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods. 2010;7(2):133-6. doi:10.1038/nmeth.1414.
1.
Rosenbluh J, Nijhawan D, Cox AG, et al. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151(7):1457-73. doi:10.1016/j.cell.2012.11.026.